- Zacks via Yahoo FinanceApr 17 14:46 PM
Kamada Ltd. KMDA announced that the FDA has acknowledged the path forward for commencing a phase III study on the inhaled Alpha-1 Antitrypsin (Inhaled AAT) product, which is being developed ...
Precision Medicine Market 2019 Global Analysis, Industry Size, Current Status by Major Key vendors and Trends by Forecast to 2022Market Watch16 hours ago
Significant CAGR Growth to Be Achieved by Antihypertensive Drugs Market by Global Trends, Size, Growth Rate by 2023Market Watch2 days ago
Type 2 Diabetes Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2023Market Watch5 days ago